AG
CGON icon

Algert Global’s CG Oncology CGON Stock Holding History

Algert Global’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.32M Buy
46,690
+27,310
+141% +$1.79M 0.04% 696
2026
Q1 		$1.31M Buy
+19,380
New +$1.1M 0.02% 809

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global's CGON Position: Q2 2026 in Review

Algert Global increased its CG Oncology (CGON) stake by 141% in Q2 2026, buying an estimated $1.79M and bringing the position to 46,690 shares worth $3.32M. The position accounts for 0.04% of the portfolio, ranked #696.

Algert Global first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Algert Global held 46,690 shares of CG Oncology worth $3.32M as of Q2 2026.
  • Algert Global bought 27,310 CG Oncology shares in Q2 2026, an estimated $1.79M.
  • CG Oncology made up 0.04% of Algert Global's portfolio in Q2 2026, its #696 holding.
  • Algert Global first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.